https://www.selleckchem.com/pr....oducts/blebbistatin.
Baseline depression and its changes over time significantly predicted greater decline in both medication adherence (βs=.15-.20, ps.05) and specific adherence (βs=-.21 to -.15, ps.05). Anxiety showed a similar trend. For perceived stress, baseline and its change significantly predicted specific adherence over 9months (βs=-.30 to -.23, ps.01), but did not predict medication adherence at 3 and 9months. Findings underline the necessity of tracking various forms of psychological distress over time for CHD patients to promote
Like
Comment
Share
